RecruitingNot ApplicableNCT06961110

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents. A Randomized, Double-blind, Parallel-group, Placebo-controlled Trial


Sponsor

Palacky University

Enrollment

60 participants

Start Date

May 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial evaluates whether molecular hydrogen supplementation enhances the effectiveness of a 4-week weight loss retreat in overweight and obese adolescents. Outcome measures include: body composition, physical status, blood samples (insulin sensitivity, lipid profiles, markers of oxidative stress and inflammation) and autonomic nervous system function.


Eligibility

Min Age: 11 YearsMax Age: 18 Years

Inclusion Criteria3

  • Body mass index indicating overweight or obesity, as determined according to the World Health Organization's international percentile charts for children aged 5-19 years.
  • Presence of a regular menstrual cycle in female participants.
  • Signed informed consent from the legal representative.

Exclusion Criteria5

  • High blood pressure.
  • Dyslipoproteinemia.
  • Cardio-respiratory disorders.
  • Musculoskeletal disorders.
  • Use of any medications regulating heart rhythm or the neurovegetative and hormonal system.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTHydrogen-rich water

Hydrogen-rich water with molecular hydrogen concentration 1.2-1.6 ppm. No added sugar or preservatives.

DIETARY_SUPPLEMENTPlacebo

Drinking water with molecular hydrogen concentration 0.0 ppm. No added sugar or preservatives.


Locations(1)

Palacky University, Faculty of Physical Culture

Olomouc, Czech Republic, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06961110


Related Trials